KAYLA EHRMAN: Open Payments
NPI 1316357494 · BETTENDORF, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$51,533 in 137 payments from 16 companies in 2025. Trend: 2023 $36,818 · 2024 $42,037 · 2025 $51,533
Consulting: $29,468Speaker / faculty: $17,700Travel & lodging: $2,396Food & beverage: $1,969
| Company | Payments | Amount |
|---|---|---|
| CSL Plasma Inc. | 49 | $29,468 |
| Lilly USA, LLC | 42 | $20,957 |
| Eisai Inc. | 23 | $640 |
| Lundbeck LLC | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| ACADIA Pharmaceuticals Inc | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| GE HEALTHCARE | 1 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| C2N Diagnostics, LLC | 1 | $28 |
Products named: KISUNLA, Leqembi, REXULTI, NUPLAZID, VYEPTI, KESIMPTA, AUSTEDO XR, PRECIVITYAD2.
Industry payments across IA — which companies pay providers there.
